Michael Schivo, M.D., M.A.S. for UC Davis Health

Michael  Schivo, M.D., M.A.S.

Michael Schivo, M.D., M.A.S.

Director, Internal Medicine Residency Research Track

Co-Director Comprehensive COPD Clinic

Professor of Clinical Internal Medicine

Chair, Clinical Research Graduate Group

To see if Michael Schivo is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Reviews

Specialties

Internal Medicine

Pulmonary Medicine

Critical Care Medicine

Department

Internal Medicine

Locations and Contact

UC Davis Medical Group - Sacramento (J Street)



,

Get Directions

Patient Support Services Building

Patient Support Services Building - Pulmonary, Critical Care, and Sleep Medicine
4150 V St.
Sacramento, CA 95817

Get Directions

Phone: 916-734-8230

Additional Numbers

Clinic Phone

916-734-8230

Clinic Fax

916-734-7924

Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Schivo believes that patients should receive the best care available. This includes thorough and compassionate clinic visits, subspecialist referrals when appropriate, and access to clinical research studies. Through this level of care and attention, Dr. Schivo believes that all patients can benefit.

Clinical Interests

Dr. Schivo is board-certified in internal medicine, pulmonary diseases, and critical care medicine. His clinical interests include airway diseases focusing on chronic obstructive pulmonary disease (COPD) and other obstructive lung diseases such as asthma. He is part of the Reversible Obstructive Airway Diseases (ROAD) Center, the UC Asthma Network (UCAN) Clinics, and the Lung Center at UC Davis. Dr. Schivo also has a general pulmonology clinic in Rocklin, CA.

Research/Academic Interests

Dr. Schivo focuses on the analysis of exhaled and emitted volatile organic compounds (VOC) with the aims of non-invasive diagnostics, disease monitoring, and evaluation of therapeutic response. He collaborates highly with biologists, chemists, chemometricians, engineers, and pediatric/adult clinicians to coordinate clinical trials utilizing VOC analysis in disease states. His research spans from in-vitro epithelial models to human subject studies. Dr. Schivo also leads the Internal Medicine Resident Research track and chairs the Clinical Research Graduate Group.

Division

Pulmonary, Critical Care, and Sleep Medicine

Undergraduate School

B.A., UC Davis, Davis CA 1998

Medical School

M.D., Drexel University College of Medicine, Philadelphia PA 2003

Other School

M.A.S., UC Davis, Davis CA 2010

Internship

Internal Medicine, UC Davis Medical Center, Sacramento CA 2003-2004

Residency

Internal Medicine, UC Davis Medical Center, Sacramento CA 2004-2007

Fellowship

Pulmonary and Critical, UC Davis Medical Center, Sacramento CA 2007-2012

UC Davis Internal Medicine Chair's Recognition Award for Service, 2018,

Joan Ottinger Memorial Research Award, UC Davis School of Medicine, 2014,

Fellow's Research Award, UC Davis Internal Medicine, 2012,

People's Choice Award, UC Davis Internal Medicine, 2010,

Golden Key Honor Society, UC Davis, 2010,

Outstanding Fellow's Award, UC Davis Pulmonary & Critical Care Medicine, 2009,

Access Michael Schivo's list of publications here: https://www.ncbi.nlm.nih.gov/myncbi/1xqMuel88ssQn/bibliography/public/

Heidari A, Kaur S, Pearson SJ, Munoz A, Sandhu H, Mann G, Schivo M, Zeki AA, Bays DJ, Wilson M, Albertson TE, Johnson R, Thompson GR. Hypoxemic Respiratory Failure and Coccidioidomycosis-Associated Acute Respiratory Distress Syndrome, Open Forum Infectious Dis. 2024;11(2):ofad679. PMCID: PMC10873137

Flayer CH, Linderholm AL, Ge MQ, Juarez M, Franzi L, Tham T, Teuber M, Liao SY, Schivo M, Kuhn B, Zeki A, Haczku A. IL-17A + group 2 innate lymphoid cells elicit mixed airway inflammation in chronic obstructive pulmonary disease, medRxiv. Nov 2023 [Preprint]. PMCID: PMC10690341.

Chalupsky MR, Craddock KM, Schivo M, Kuhn BT. Remote patient monitoring in the management of chronic obstructive pulmonary disease, J Investig Med. 2022 Dec;70(8):1681-1689. doi: 10.1136/jim-2022-002430. Epub 2022 Jun 16. Review. PubMed PMID: 35710143.

Hu S, McCartney MM, Arredondo J, Sankaran-Walters S, Borras E, Harper RW, Schivo M, Davis CE, Kenyon NJ, Dandekar S. Inactivation of SARS-CoV-2 in clinical exhaled breath condensate samples for metabolomic analysis, J Breath Res. 2021 Dec 20;16(1). 

McCartney MM, Linderholm AL, Yamaguchi MS, Falcon AK, Harper RW, Thompson GR, Ebeler SE, Kenyon NJ, Davis CE, Schivo M. Predicting Influenza and Rhinovirus Infections in Airway Cells Utilizing Volatile Emissions, J Infect Dis. 2021 Nov 22;224(10):1742-1750. 

Borras E, McCartney MM, Thompson CH, Meagher RJ, Kenyon NJ, Schivo M, Davis CE. Exhaled breath biomarkers of influenza infection and influenza vaccination, J Breath Res. 2021 Aug 19;15(4). 

Mitra A, Dwyre D, Schivo M, Thompson G, Cohen S, Ku N, Graff J. Leukoerythroblastic reaction in a patient with COVID-19 infection, American Journal of Hematology. (2020).

Sanville B, Corbett R, Pidcock W, Hardin K, Sebat C, Nguyen M, Thompson G, Hackzu A, Schivo M, Cohen S. A Community Transmitted Case of Severe Acute Respiratory Distress Syndrome due to SARS CoV2 in the United States, Clinical Infectious Diseases. 2020;1-15.

McCartney M, Yamaguchi M, Bowles P, Gratch Y, Lyer R, Linderholm A, Ebeler S, Kenyon N, Schivo M, Harper R. Volatile Organic Compound (VOC) Emissions of CHO and T Cells Correlate to their Expansion in Bioreactors, Journal of Breath Research. 14(2020): 1-14. 

Borras E, Cheng A, Wun T, Reese K, Reese KL, Schivo M, Davis C. Detecting Opoid Metabolites in Exhaled Breath Condensate (EBC), Journal of Breath Research. 13(2019): 1-11.